0001246360-15-002838.txt : 20150810
0001246360-15-002838.hdr.sgml : 20150810
20150810162812
ACCESSION NUMBER: 0001246360-15-002838
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150806
FILED AS OF DATE: 20150810
DATE AS OF CHANGE: 20150810
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NxStage Medical, Inc.
CENTRAL INDEX KEY: 0001333170
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 043454702
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 350 MERRIMACK STREET
CITY: LAWRENCE
STATE: MA
ZIP: 01843
BUSINESS PHONE: 978-687-4700
MAIL ADDRESS:
STREET 1: 350 MERRIMACK STREET
CITY: LAWRENCE
STATE: MA
ZIP: 01843
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TOWSE MATTHEW W
CENTRAL INDEX KEY: 0001195852
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51567
FILM NUMBER: 151041095
4
1
form.xml
PRIMARY DOCUMENT
X0306
4
2015-08-06
false
0001333170
NxStage Medical, Inc.
NXTM
0001195852
TOWSE MATTHEW W
350 MERRIMACK STREET
LAWRENCE
MA
01843
false
true
false
false
SVP and Chief Financial Office
Common Stock
2015-08-06
4
S
false
5455
15.52
D
12947
D
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2015.
This represents the weighted average price for shares sold in multiple transactions at prices ranging from $15.50 to $15.61, inclusive. Full information regarding the number of shares sold at each separate price within the range will be provided to NxStage Medical, Inc., any security holder of NxStage Medical, Inc. or the staff of the Securities and Exchange Commission, upon request.
Aras Lapinskas, attorney-in-fact for Matthew W. Towse
2015-08-10